Viewing Study NCT03185494


Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2026-01-07 @ 12:09 AM
Study NCT ID: NCT03185494
Status: UNKNOWN
Last Update Posted: 2019-04-17
First Post: 2017-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22
Sponsor: Chinese PLA General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module